Skip to main content
Top

Drugs

Issue 9/2012

Content (11 Articles)

Unboosted Atazanavir for Treatment of HIV Infection

  • Current Opinion

Emanuele Focà, Diego Ripamonti, Davide Motta, Carlo Torti

Overcoming Treatment Resistance in HER2-Positive Breast Cancer

  • Leading Article

Fabio Puglisi, Alessandro Marco Minisini, Carmine De Angelis, Grazia Arpino

Invasive Group A Streptococcal Disease

  • Review Article

Andrew C. Steer, Theresa Lamagni, Nigel Curtis, Jonathan R. Carapetis

Mometasone/Formoterol Inhalation Aerosol

  • Adis Drug Profile

James E. Frampton

Bilastine

  • Adis Drug Profile

Natalie J. Carter

Apixaban

  • Adis Drug Evaluation

Emma D. Deeks

Mogamulizumab

  • R&D Insight Profile

Joshuan M. Subramaniam, Glenn Whiteside, Kate McKeage, Jamie C. Croxtall

HIV-1 Antiretroviral Resistance

  • Open Access
  • Review Article

Michele W. Tang, Robert W. Shafer

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images